While bone-derived DKK1 contributes to the systemic elevation of DKK1 during tumor progression, CAFs represent the primary source of DKK1 at the tumor site, suppressing NK cell-mediated tumoricidal activity. The gene discussed is DKK1; the disease is neoplasm.